DLA PIPER LLP (US) for NOVO NORDISK INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
National Diabetes Prevention Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL NEWBOLD CASTLE | — |
| KRISTA DROBAC | — |
| TIFFANI WILLIAMS | — |
Health Issues HCR
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI | — |
| MICHAEL NEWBOLD CASTLE | — |
| VANESSA L. CRAMER New | Legislative Correspondent, Rep. Ackerman |
| KRISTA DROBAC | — |
| KRISTEN RATCLIFF | — |
| TIFFANI WILLIAMS | — |
Medicare/Medicaid MMM
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLE CARELLI | — |
| VANESSA L. CRAMER New | Legislative Correspondent, Rep. Ackerman |
| KRISTA DROBAC | — |
| KRISTEN RATCLIFF | — |
| TIFFANI WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.